(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists
In two large studies, Lipfendra lowered LDL cholesterol (LDL-C) by more than half compared with a placebo a 56% reduction in one trial of adults with heart disease or high risk for it, and a 59% reduction in a second trial of people with the inherited form of high cholesterol
FDA has issued a box warning of the risk of thyroid cancers and are contraindicated liraglutide, exenatide (once weekly), and semaglutide (both oral and injectable) in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia types 2 A or 2B [135, 136]
These treatments are tailored to meet personal needs and goals, providing a safe and effective approach
But with a drug this potent, the bodys response can be more complex than simple appetite suppression